CHEMBIO DIAGNOSTICS, INC. Executive Retention AgreementExecutive Retention Agreement • February 14th, 2023 • Chembio Diagnostics, Inc. • Pharmaceutical preparations • New York
This Executive Retention Agreement (this “Agreement”) is entered into between Chembio Diagnostics, Inc., a Nevada corporation (the “Company”), and Paul J. Angelico (the “Executive” and, together with the Company, the “Parties”) as of the date set forth on the signature page hereof (the “Effective Date”).
NON-DISCLOSURE, INTELLECTUAL PROPERTY, NON-COMPETITION AND NON-SOLICITATION AGREEMENTNon-Competition and Non-Solicitation Agreement • February 14th, 2023 • Chembio Diagnostics, Inc. • Pharmaceutical preparations
This Non-Disclosure, Intellectual Property, Non-Competition And Non-Solicitation Agreement (the “Agreement”) is entered into as of March 16, 2020 between Chembio Diagnostics, Inc. (the “Company”) and Richard L. Eberly (the “Executive,” and, together with the Company, the “Parties”).
NON-DISCLOSURE, INTELLECTUAL PROPERTY, NON-COMPETITION AND NON-SOLICITATION AGREEMENTNon-Solicitation Agreement • February 14th, 2023 • Chembio Diagnostics, Inc. • Pharmaceutical preparations
This Non-Disclosure, Intellectual Property, Non-Competition and Non-Solicitation Agreement (the “Agreement”) is entered into between Chembio Diagnostics, Inc., a Nevada corporation (the “Company”), and Charles Caso (the “Executive” and, together with the Company, the “Parties”) as of the date set forth on the signature page hereof. The Parties are entering into this Agreement contemporaneously with, and as a condition to, their execution and delivery of an Executive Retention Agreement dated as of the date hereof (the “Executive Retention Agreement”).
